Skip to content
Future Palace

The Zimbabwean Government Turns Down ‘One-Sided’ US Healthcare Assistance Package Over Data Concerns

Medical funding image
The offered American funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has declined a substantial US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's insistence on sensitive biological samples.

This move became public after a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the deal was "lopsided".

A government spokesperson later clarified that the US was requesting genetic material for scientific study and profit while was not willing to guarantee the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate process of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for more talks to reach a deal agreeable to both sides so the country's critical HIV programme can be sustained.

Broader Context

This rejection comes after a similar case in neighbouring Kenya, where a court suspended a related deal with the US following concerns were raised about the security of Kenyans' medical information.

After resuming office last year, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.

USAID had managed aid for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance transparency and responsibility.

Based on reports, 16 African countries have to date agreed to these new health pacts, constituting more than $18.3bn in new funding.

Specifics of the Declined Deal

This assistance for Zimbabwe was intended to supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on HIV treatment via US-supported programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".

"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.

"Put simply, our nation would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our citizens if a future pandemic arise."

Sovereignty and Global Health

He also said that the American exit from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks previously established via the international organization.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.

"This system is intended to ensure that when a nation contributes its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised solely by those with the funds to develop them."

Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.

"We encourage further dialogue with our American counterparts on how future collaboration could be arranged in a way that respects the independence and interests of both nations."

Health Experts Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but suggested that negotiations should continue considering a large portion of the country's HIV programmes were funded by international support.

"In cases where technical issues exist, including those relating to information security or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," it said.

The situation underscores the continuing challenges between receiving crucial foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.

Written by

Carl Forbes

A tech futurist and AI researcher passionate about exploring how digital advancements transform society and daily life.

Future Palace

Type to search articles.